Giordano Bottà PhD

Giordano Bottà PhD is the CEO and Co-Founder of Allelica, a company focused on advancing precision medicine to improve human health.1 He has a strong background in public health and genomics, holding a PhD in Public Health.

Professional Experience

As the CEO of Allelica, Dr. Bottà is actively involved in various aspects of the company's operations and outreach:

• He frequently presents at industry conferences and events, sharing insights on precision medicine and genetic biomarkers.24
• Dr. Bottà participates in discussions with pharmaceutical and biotech companies about the use of Polygenic Risk Scores (PRS) in clinical trials and target identification.5
• He is passionate about using new genetic biomarkers to accelerate and de-risk clinical trials for developing innovative therapies.3

Academic Background

Giordano Bottà's academic credentials include:

• A PhD, likely in Public Health or a related field.
• Association with Sapienza Università di Roma, though the exact nature of this connection is not specified in the provided information.1

Recent Activities

Dr. Bottà maintains an active professional presence, as evidenced by his LinkedIn activities:

• He presented at the Multiomics in Precision Medicine 2024 event, discussing Allelica's approach to precision medicine.2
• In February 2024, he participated in the MedLab Middle East 2024 Conference in Dubai.4
• He attended an event in London focused on using genetic biomarkers in clinical trials.3

Giordano Bottà's work at Allelica and his involvement in various industry events demonstrate his commitment to advancing the field of precision medicine and leveraging genetic information to improve healthcare outcomes.